Dr. Flowers is an internationally-recognized expert in lymphoma epidemiology and outcomes research.
Titles and Roles
- Director of the Emory Lymphoma Program
- Winship Cancer Institute of Emory University
- Associate Professor, Department of Hematology and Medical Oncology
- Emory University School of Medicine
- Research Program
- Cancer Prevention and Control
Christopher R. Flowers, MD currently serves as Associate Professor of hematology and medical oncology at the Emory University School of Medicine. He is a member of the Emory Stem Cell and Bone Marrow Transplant team. Through the lymphoma clinic, Dr. Flowers offers a variety of clinical trials and advanced treatment algorithms for patients with lymphoma. His clinic focuses on specialized care for patients with lymphoid malignancies involving multi-specialty input from hematopathologists, immunologists, surgeons, radiation oncologists, and specialists in nuclear medicine and bone marrow transplantation.
Dr. Flowers is a member of InterLymph, an international collaboration of experts in lymphoma epidemiology that is focused on finding the causes for lymphoma. This group completed the first study to assemble data from lymphoma patients across the world to identify factors that may cause specific types of lymphoma. The Lymphoma Program at Emory has been a key contributor in clinical trials that have led to FDA approval of new drugs for cancer patients. Dr. Flowers also has been instrumental in developing national guidelines for the management of cancer patients with the American Society of Clinical Oncology, the American College of Radiology, and the American Cancer Society.
Dr. Christopher Flowers graduated from Stanford University from the Human Biology and Humanities honors programs. He remained at Stanford where he completed medical school and a master's degree in Medical Information Sciences. After medical school, he returned to Seattle where he completed internal medicine residency at the University of Washington. After residency, Dr. Flowers continued his research training in Seattle through the Robert Wood Johnson Clinical Scholars Program and oncology fellowship at the Fred Hutchinson Cancer Research Center. At the University of Washington, he collaborated on studies that investigated the cost effectiveness of pharmacogenomics in oncology, and developed clinical and translational studies in chronic lymphocytic leukemia and non-Hodgkin's lymphoma.
Dr. Flowers' current research projects span three areas:
1) epidemiology, outcomes, translational research and clinical trials in lymphoma
2) oncology informatics projects developing an information infrastructure to support pharmacogenomics and cancer outcomes research
3) medical decision analyses and cost-effectiveness analyses aimed at developing strategies to individualize care for cancer patients.
Dr. Flowers has published over 100 peer reviewed articles in elite journals including the New England Journal of Medicine, Nature Medicine, Nature Genetics, and the Journal of Clinical Oncology.
Dr. Flowers recent awards include:
- Georgia Cancer Coalition Distinguished Cancer Clinician and Scientist Award
- James R. Eckman Excellence in Teaching of Fellows Award, Winship Cancer Institute of Emory University
- Amos Faculty Development Award: American Society of Hematology / Robert Wood Johnson Foundation
- ASH Travel Award: American Society of Hematology